You must be 21 years of age or older to enter this site.
By entering, you confirm you are 21 years of age or older.
The BPC/TB Blend is a precision-formulated combination of two extensively studied research peptides: BPC-157 (Body Protection Compound-157) at 10mg and TB-500 (Thymosin Beta-4 Fragment) at 10mg. This 20mg total blend provides researchers with a convenient dual-compound formulation for studies examining synergistic peptide interactions in controlled laboratory settings.
BPC-157 is a 15-amino acid pentadecapeptide derived from a partial sequence of the human body protection compound protein. TB-500, a 43-amino acid synthetic fragment of Thymosin Beta-4, has been the subject of extensive preclinical research examining its interactions with actin-binding proteins and cellular signaling cascades. The combination of these two peptides in a single lyophilized formulation enables streamlined research protocols.
AXOM BPC/TB Blend is manufactured under strict cGMP-equivalent protocols and verified to ≥99% purity for each component via reverse-phase HPLC. Each lot is accompanied by a Certificate of Analysis documenting identity, purity, peptide content, and endotoxin levels. For research and laboratory use only.
Combines BPC-157 (10mg) and TB-500 (10mg) in a single lyophilized vial, enabling streamlined multi-compound research protocols without separate reconstitution steps.
Designed for in-vitro studies examining the interactions between pentadecapeptide and thymosin beta-4 fragment signaling pathways in controlled laboratory environments.
≥99% HPLC-verified purity for each component with full COA documentation. Every lot independently tested by third-party analytical laboratories.
Comprehensive review of over 20 years of published research on the stable gastric pentadecapeptide BPC 157. Examines the peptide's molecular interactions with the NO system, prostaglandin system, and dopamine system in in-vitro and preclinical models.
Detailed analysis of Thymosin Beta-4 (the parent molecule of TB-500) and its characterized interactions with G-actin monomers, examining the peptide's role in cellular migration and cytoskeletal organization in preclinical research models.
In-vitro study examining the effects of BPC 157 on tendon fibroblast cell cultures. Characterized the peptide's influence on cell migration, survival, and outgrowth in controlled laboratory conditions using standardized fibroblast assay protocols.
| Product Name | BPC/TB Blend (BPC-157 + TB-500) |
| Composition | BPC-157 10mg + TB-500 10mg (20mg total) |
| CAS Number | Blend — No single CAS (BPC-157: 137525-51-0 / TB-500: 77591-33-4) |
| Combined Molecular Weight | ~2,837 Da |
| BPC-157 Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 aa) |
| TB-500 Sequence | 43-amino acid synthetic fragment of Thymosin Beta-4 |
| Purity | ≥99% per component (Reverse-Phase HPLC) |
| Form | Lyophilized white powder |
| Available Sizes | 20mg (10mg + 10mg) |
| Solubility | Soluble in sterile water, bacteriostatic water |
| Endotoxin | <1 EU/μg (LAL method) |
| Certification | COA included with every order |
| Intended Use | For research and laboratory use only |
BPC/TB Blend is supplied as a lyophilized powder and should be reconstituted with sterile bacteriostatic water (BAC water) for research applications.
All orders ship within the continental United States via USPS or UPS. Peptides are shipped at ambient temperature — lyophilized peptides are stable during transit. Free shipping on orders over $250.
Buy more of the same item and save automatically at checkout. No code needed.